Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

U.S. Contract Research Organization (CROs) Market – Increasing Number of Clinical Trials Leading Growth of the U.S. Contract Research Organization (CROs) Market

A contract research organization (CRO) are service provider organization that offers various drug developmental and clinical data management services supporting pharmaceutical and biotechnology industries engaged in clinical trials, in the form of outsourced pharmaceutical research services (for both drugs and medical devices). CROs range from large, medium to small, niche specialty groups.

Increasing adoption of regulatory outsourcing services by pharmaceutical and other industries, in order to gain various grants such as fast track designation and orphan drug designation for their products to gain faster approvals in the market are expected to propel the market growth over the forecast period. Many rare diseases are left untreated despite over 500 orphan drug therapies approved in the U.S. For instance, in 2018, according to the Center for Drug Evaluation and Research, a division of the U.S. FDA, 34 out of 59 novel drugs were approved for treating orphan diseases in the U.S.

The U.S. contract research organization (CROs) market is estimated to be valued at US$ 12,174.4 million in 2019, and is expected to exhibit a CAGR of 9.4% during the forecast period (2019-2027).

Figure 1. U.S. Contract Research Organization (CROs) Market Value (US$ Mn) Analysis & Forecast and Y-o-Y Growth (%), 2016-2027

U.S. Contract Research Organizations (CROs)  | Coherent Market Insights

Source: Coherent Market Insights

Increasing technological advancements such as use of artificial intelligence and machine learning in the field of clinical research are expected to drive growth of the U.S. contract research organization (CROs) market during the forecast period.

Increasing use of artificial intelligence and machine learning along with big data is expected to improve the efficiency of clinical trial process and help speed up drug approval process. Artificial intelligence can help in identifying potential hazards in the clinical development process at an early stage, thereby allowing researchers to reduce the cost and time required for research. Artificial Intelligence can also be used in combination with wearable devices for processing and analyzing multiple real-time data. Effective use of wearable sensors can reduce the need for patients to travel for site visits during clinical trials. The system can also be used to compare data sets from ongoing trials and patients’ medical records, and make necessary suggestions. These factors are expected to fuel growth of the market over the forecast period. For instance, in June 2018, BioClinica, a global life science service provider, expanded and enhanced SMART technology suite equipped with medical imaging, electronic data capture (EDC), and interactive response technology (IRT) technologies for efficient analysis of clinical trial data.

However, fluctuation in prices and hidden cost of clinical research services are the major factors that are expected to hinder the market growth over the forecast period. Moreover, other costs are involved in the services with increasing use of technological platforms, which includes software for clinical data management, database, document management, and others. Usage of such advanced technology enhances the overall process and provides quality data, however, it increases the cost of outsourcing services, which in turn is expected to hamper growth of the U.S. contract research organization (CROs) market during the forecast period.

Global U.S. contract research organization (CROs) market - Competitive Landscape

Some of the major companies offering clinical trial management systems include Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel International Corporation, Syneos Health, PRA Health Sciences, Charles River Laboratoires International Inc. (CRL), Pharmaceutical Product Development (PPD), ICON Public Limited Corporation, Wuxi Apptec, Medpace Holdings, Inc, Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, Clinipace, CMIC Holdings Co., Ltd, EPS International, Synteract, CROMSOURCE, Pharm-Olam, Linical Accelovance, Accumedix, Inc., AlcheraBio LLC, Amarex Clinical Research LLC, Arianne Corporation, Absolute Research Solutions, BioClinica Inc., BioPharma Services Inc., Neurovasc Preclinical Services, Inc., PSI, WCCT Global Inc., RHO, Inc., CATO Research LLC, Spaulding Clinical Research, Celerion, Clindatrix, Inc., Comparative Biosciences, Inc., Axiom Real-Time Metrics, CPC Clinical Research, Axis Clinicals LLC, DP Clinical, Egeen Inc., Grayline, Cmed, Integrium, LLC, MedTrials, Novum, Shin Nippon Biomedical Laboratories, Ltd., KPS Life, Pinnacle Research Group, LLC Promedica International., Alta Science, Prometrika, LLC, 4clinics, and Premier Research.

A contract research organization (CRO) offers effective services to pharmaceutical and biotechnology organizations by reducing cost and time period required to conduct the clinical trial. The U.S. continues to be the one of the largest market for pharmaceutical research and development, thereby providing growth opportunities for contract research organizations (CROs). CROs offer drug discovery services such as drug target identification, drug discovery screening, library screening, fragment-based drug design, ligand-based drug design, ligand protein binding, drug profiling, lead identification, lead compound identification, and lead optimization. CROs conducts clinical trial studies (from phase I to phase IV). It is also engaged in medical coding, monitoring, clinical data management, protocol development, and other services which are included in clinical development of any drug molecules.

Market Dynamics

Rising number of U.S. Food and Drug Administration (FDA) approvals and clinical trials are supporting growth of biopharmaceutical industry are expected to fuel growth of the U.S. contract research organization (CROs) market. The U.S. is expected to hold dominant position in the contract research organization market over the forecast period due to rising demand for generic drugs, increasing clinical research and development activities, and government support. The U.S. is one of the biggest market for contract research organization due increasing pharmaceutical research and development activities in the country, thereby providing growth opportunities for contract research organizations (CROs). For instance, according to the clinicaltrials.gov, from September 2008 to October 2019, around 34% (125,000) of clinical trial studies were performed in the U.S. out of 317,865 studies, globally.

Key features of the study:

  • This report provides in-depth analysis of the U.S. contract research organization (CROs) market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2019-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline drugs, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global U.S. contract research organization (CROs) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Key companies covered as a part of this study include Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel International Corporation, Syneos Health, PRA Health Sciences, Charles River Laboratoires International Inc. (CRL), Pharmaceutical Product Development (PPD), ICON Public Limited Corporation, Wuxi Apptec,Medpace Holdings, Inc,Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, Clinipace, CMIC Holdings Co., Ltd, EPS International, Synteract, CROMSOURCE, Pharm-Olam, Linical Accelovance, Accumedix, Inc., AlcheraBio LLC, Amarex Clinical Research LLC, Arianne Corporation, Absolute Research Solutions, BioClinica Inc., BioPharma Services Inc., Neurovasc Preclinical Services, Inc., PSI, WCCT Global Inc., RHO, Inc., CATO Research LLC, Spaulding Clinical Research, Celerion, Clindatrix, Inc., Comparative Biosciences, Inc., Axiom Real-Time Metrics, CPC Clinical Research, Axis Clinicals LLC, DP Clinical, Egeen Inc., Grayline, Cmed, Integrium, LLC, MedTrials, Novum, Shin Nippon Biomedical Laboratories, Ltd., KPS Life, Pinnacle Research Group, LLC Promedica International., Alta Science, Prometrika, LLC, 4clinics, and Premier Research.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launches, market expansion, and marketing tactics
  • The global U.S. contract research organization (CROs) market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, CROs, medical device companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the U.S. contract research organization (CROs) market

Detailed Segmentation:

  • U.S. Contract Research Organization (CROs) Market, By Service Type:
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - IIa
    • Phase IIa - III
    • Phase IIIb – IV
    • Drug Development
    • Medical Coding and Writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site Management
    • Protocol Development
    • Biomarker Discovery
  • U.S. Contract Research Organization (CROs) Market, By Therapeutic Application:
    • Oncology
    • Cardiovascular Diseases
    • Central Nervous System Diseases
    • Infectious Diseases
    • Metabolic Disorders
    • Immunological Disorders
    • Respiratory Disorders
    • Others
  • U.S. Contract Research Organization (CROs) Market, By Size of CRO:
    • Small Size
    • Medium Size
    • Large Size
  • Company Profiles
    • Laboratory Corporation of America Holdings (Covance) *
      • Company Overview
      • Product Portfolio
      • Market Presence
      • Financial Overview
      • Key Developments
      • Strategies
    • IQVIA
    • Paraxel International Corporation
    • Syneos Health
    • PRA Health Sciences
    • Charles River Laboratoires International Inc. (CRL)
    • Pharmaceutical Product Development (PPD)
    • ICON Public Limited Corporation
    • Wuxi Apptec
    • Medpace Holdings, Inc
    • Medidata Solutions, Inc.
    • Theorem Clinical Research
    • Pharmaron
    • Envigo
    • Clinipace
    • CMIC Holdings Co., Ltd
    • EPS International
    • Synteract
    • CROMSOURCE
    • Pharm-Olam
    • Linical Accelovance
    • Accumedix, Inc.
    • AlcheraBio LLC
    • Amarex Clinical Research LLC
    • Arianne Corporation
    • Absolute Research Solutions
    • BioClinica Inc.
    • BioPharma Services Inc.
    • Neurovasc Preclinical Services, Inc.
    • PSI
    • WCCT Global Inc
    • RHO, Inc.
    • CATO Research LLC
    • Spaulding Clinical Research
    • Celerion
    • Clindatrix, Inc.
    • Comparative Biosciences, Inc.
    • Axiom Real-Time Metrics
    • CPC Clinical Research
    • Axis Clinicals LLC
    • DP Clinical
    • Egeen Inc.
    • Grayline
    • Cmed
    • Integrium, LLC
    • MedTrials
    • Novum
    • Shin Nippon Biomedical Laboratories, Ltd.
    • KPS Life
    • Pinnacle Research Group, LLC
    • Promedica International.
    • Alta Science
    • Prometrika, LLC
    • 4clinics
    • Premier Research

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Service Type
      • Market Snippet, By Therapeutic Application
      • Market Snippet, By Size of CRO
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints & Challenges
      • Market Opportunities
      • Merger and Acquisitions
      • Key to a Successful CTMS Solution
  4. U.S. Contract Research Organization (CROs) Market, By Service Type, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2016 - 2027
      • Segment Trends
    • Drug Discovery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Preclinical studies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Early Phase I – Iia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Phase IIa – III
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Phase IIIb – IV
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Drug Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Medical Coding and Writing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Monitoring
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Clinical Data Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Bio-statistics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Site Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Protocol Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Biomarker Discovery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  5. U.S. Contract Research Organization (CROs) Market, By Therapeutic Application, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2016 - 2027
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Central Nervous System Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Metabolic Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Immunological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Respiratory Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  6. U.S. Contract Research Organization (CROs) Market, By Size of CRO, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016 – 2027
      • Segment Trends
    • Small Size
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Medium Size
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Large Size
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Laboratory Corporation of America Holdings (Covance) *
        • Company Overview
        • Product Portfolio
        • Market Presence
        • Financial Overview
        • Key Developments
        • Strategies
      • IQVIA
      • Paraxel International Corporation
      • Syneos Health
      • PRA Health Sciences
      • Charles River Laboratoires International Inc. (CRL)
      • Pharmaceutical Product Development (PPD)
      • ICON Public Limited Corporation
      • Wuxi Apptec
      • Medpace Holdings, Inc
      • Medidata Solutions, Inc.
      • Theorem Clinical Research
      • Pharmaron
      • Envigo
      • Clinipace
      • CMIC Holdings Co., Ltd
      • EPS International
      • Synteract
      • CROMSOURCE
      • Pharm-Olam
      • Linical Accelovance
      • Accumedix, Inc.
      • AlcheraBio LLC
      • Amarex Clinical Research LLC
      • Arianne Corporation
      • Absolute Research Solutions
      • BioClinica Inc.
      • BioPharma Services Inc.
      • Neurovasc Preclinical Services, Inc.
      • PSI
      • WCCT Global Inc
      • RHO, Inc.
      • CATO Research LLC
      • Spaulding Clinical Research
      • Celerion
      • Clindatrix, Inc.
      • Comparative Biosciences, Inc.
      • Axiom Real-Time Metrics
      • CPC Clinical Research
      • Axis Clinicals LLC
      • DP Clinical
      • Egeen Inc.
      • Grayline
      • Cmed
      • Integrium, LLC
      • MedTrials
      • Novum
      • Shin Nippon Biomedical Laboratories, Ltd.
      • KPS Life
      • Pinnacle Research Group, LLC
      • Promedica International.
      • Alta Science
      • Prometrika, LLC
      • 4clinics
      • Premier Research
    • Analyst Views
  8. Section
    • Research Methodology
    • About us and Services

*Browse 09 market data tables and 27 figures on "U.S. Contract Research Organization (CROs) Market - Global forecast to 2027”.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The U.S. contract research organization (CROs) market is estimated to exhibit a CAGR of 9.4% over the forecast period (2019-2027).
Some of the major players operating in the U.S. contract research organization (CROs) market include Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel International Corporation, Syneos Health, PRA Health Sciences, Charles River Laboratoires International Inc. (CRL), Pharmaceutical Product Development (PPD), ICON Public Limited Corporation, Wuxi Apptec, Medpace Holdings, Inc, Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, Clinipace, CMIC Holdings Co., Ltd, EPS International, Synteract, CROMSOURCE, Pharm-Olam, Linical Accelovance, Accumedix, Inc., CATO Research LLC, Spaulding Clinical Research, Celerion, and Clindatrix, Inc., among others.
Fluctuation in the prices and hidden cost of clinical research services is one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing technological advancements such as use of artificial intelligence and machine learning in the field of clinical research is the major factor that is expected to propel growth of the market over the forecast period.
The U.S. contract research organization (CROs) market is estimated to account for US$ 12,174.4 million in 2019.
The U.S. contract research organization (CROs) market is estimated to reach US$ 25,049.0 million by 2027.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner